CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

118 hedge funds and large institutions have $213M invested in Cymabay Therapeutics in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+5
Holders Change %
+4.42%
% of All Funds
1.87%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
22
Increased
38
Reduced
25
Closed
17
Calls
$805K
Puts
$456K
Net Calls
+$349K
Net Calls Change
+$956K

Top Buyers

1
CC
1
Commodore Capital
New York
$17.8M
2
Millennium Management
2
Millennium Management
New York
$7.38M
3
Citadel Advisors
3
Citadel Advisors
Florida
$3.01M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.43M
5
HS
5
HighVista Strategies
Massachusetts
$645K

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
SCM
2
Stonepine Capital Management
Oregon
$0
3
Massachusetts Financial Services
3
Massachusetts Financial Services
Massachusetts
$0
4
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$31.1K
5
NCM
5
Nantahala Capital Management
Connecticut
$5.89M
Name Holding Trade Value Shares
Change 		Shares
Change %
SCM
26
Sio Capital Management
New York
$1.75M – – –
VVM
27
Versant Venture Management
California
$1.69M – – –
Renaissance Technologies
28
Renaissance Technologies
New York
$1.43M +$758K +243,915 +113%
PPA
29
Parametric Portfolio Associates
Washington
$1.04M +$298K +95,698 +40%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$965K +$197K +63,494 +26%
Nuveen Asset Management
31
Nuveen Asset Management
Illinois
$924K +$16.8K +5,245 +2%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$861K +$68.3K +21,961 +9%
FI
33
Fosun International
China
$819K – – –
Charles Schwab
34
Charles Schwab
California
$744K +$184K +59,256 +33%
Rockefeller Capital Management
35
Rockefeller Capital Management
New York
$707K +$1.63K +525 +0.2%
Invesco
36
Invesco
Georgia
$692K -$120K -38,712 -15%
HS
37
HighVista Strategies
Massachusetts
$645K +$645K +207,307 New
BCM
38
Bridgeway Capital Management
Texas
$602K +$467K +150,000 +345%
GCP
39
GSA Capital Partners
United Kingdom
$598K -$118K -38,014 -17%
Deutsche Bank
40
Deutsche Bank
Germany
$512K -$14.2K -4,577 -3%
CM
41
CM Management
Florida
$467K – – –
CAM
42
ClariVest Asset Management
California
$413K -$60.6K -19,500 -13%
A
43
Abingworth
United Kingdom
$406K – – –
Two Sigma Advisers
44
Two Sigma Advisers
New York
$395K -$187K -60,100 -32%
Morgan Stanley
45
Morgan Stanley
New York
$388K +$42.8K +13,720 +12%
CANY
46
Caxton Associates (New York)
New York
$367K +$367K +117,902 New
T. Rowe Price Associates
47
T. Rowe Price Associates
Maryland
$342K +$41.8K +13,472 +14%
AllianceBernstein
48
AllianceBernstein
Tennessee
$332K +$1.25K +400 +0.4%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$316K -$12.8K -4,107 -4%
RJA
50
Raymond James & Associates
Florida
$304K +$63.3K +20,337 +26%
1
2
3 4 5